Finance

Lists
Q3 2026 earnings • released • EPS beat +57.14% • Revenue beat +5.55%
See results
APYX:NASDAQ
Apyx Medical Inc
$2.93
-4.25%
(-0.13) 1D
$2.87
-2.05% (-0.060)
After hours
Closed: Nov 6, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APYX...
Open
$3.05
High
$3.30
Low
$2.80
Mkt. cap
123.42M
Avg. vol.
183.12K
Volume
201.25K
52-wk high
$5.08
52-wk low
$2.25
EPS
-$0.20
Beta
1.47
Shares outstanding
42.12M
No. of employees
205
Open
$3.05
High
$3.30
Low
$2.80
Mkt. cap
123.42M
Avg. vol.
183.12K
Volume
201.25K
52-wk high
$5.08
52-wk low
$2.25
EPS
-$0.20
Beta
1.47
Shares outstanding
42.12M
No. of employees
205
News stories
From web sources and news partners
About Apyx Medical Inc
CEO-
Employees205
Founded1982
HeadquartersClearwater, Florida, United States
SectorHealth Care
IndustryMedical device
Websiteapyxmedical.com
Analyst ratings
Based on 3 analysts giving stock ratings to APYX in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for APYX in the last 3 months.
Highest
Current $2.93
$7.00 (+138.91%)
Average
$6.33 (+116.04%)
Lowest
$6.00 (+104.78%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anthony Vendetti
Maxim Group
Buy
Reiterated
$6.00
+104.8%
11/05/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$7.00
+138.9%
11/06/2026
Sam Eiber
BTIG
Buy
Reiterated
$6.00
+104.8%
11/05/2026
Matt Hewitt
Craig-Hallum
Buy
Reiterated
$6.00
+104.8%
05/08/2026
Kyle Bauser
Roth MKM
Buy
Reiterated
$6.00
+104.8%
04/14/2026
Last report
Nov 5, 2026
Fiscal period
Q3 2026
-$0.04 / -$0.09
+57.14%beat
Revenue / Est. (USD)
14.03M / 13.29M
+5.55%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
19.16M
12.49M
13.88M
14.03M
Cost of goods sold
7.16M
4.56M
5.01M
-
Cost of revenue
7.16M
4.56M
5.01M
-
Research and development expenses
944.00K
765.00K
793.00K
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.04M
8.07M
9.88M
-
Operating expense
11.99M
8.84M
10.68M
-
Total operating expenses
19.15M
13.40M
15.69M
-
Operating income
11.00K
-911.00K
-1.81M
-
Other non operating income
16.00K
36.00K
2.00K
-
EBT including unusual items
-1.15M
-2.00M
-2.95M
-
EBT excluding unusual items
-1.15M
-2.00M
-2.95M
-
Income tax expense
94.00K
143.00K
124.00K
-
Effective tax rate
-8.20%
-7.15%
-4.21%
-
Other operating expenses
-
-
-
-
Net income
-1.30M
-2.11M
-3.24M
-
Net profit margin
-6.78%
-16.88%
-23.36%
-
Earnings per share
-0.03
-0.05
-0.07
-0.04
Interest and investment income
234.00K
244.00K
250.00K
-
Interest expense
-1.41M
-1.37M
-1.39M
-
Net interest expenses
-1.17M
-1.12M
-1.14M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
232.00K
-709.00K
-1.61M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps